Regnase-1抑制TCF-1+前体耗竭T细胞形成从而限制CAR-T对ALL的应答
该研究在免疫健全小鼠B-ALL模型及人CAR-T细胞中证实,Regnase-1缺陷通过直接靶向Tcf7 mRNA促进TCF-1表达,增加TCF-1+前体耗竭T细胞(TPEX)形成,增强CAR-T扩增、记忆样细胞形成和持久性,改善肿瘤清除与复发保护。
要点
- Regnase-1缺陷促进TCF-1表达和TPEX形成,增强CAR-T持久性与功能。
- Regnase-1直接靶向Tcf7 mRNA,缺陷减少耗竭并增强TCF-1- CAR-T活性。
- 人CAR-T中Regnase-1缺陷同样增强肿瘤清除和TCF-1+ CAR-T扩增。
核心结论
- Regnase-1是限制CAR-T细胞长寿与效力的调节因子,可通过调控TPEX和TCF-1影响疗效。
研究设计与样本
- 免疫健全小鼠B-ALL模型及人CAR-T细胞、异种移植B-ALL模型研究。
主要发现
- Regnase-1缺陷促进TCF-1表达,增加TPEX形成并增强CAR-T扩增与记忆样细胞形成。
- Regnase-1缺陷改善CAR-T肿瘤清除、持续缓解及二次肿瘤攻击保护。
- 表型、转录和表观遗传分析显示Regnase-1缺陷CAR-T细胞肿瘤依赖性TPEX编程增加。
- Regnase-1直接靶向Tcf7 mRNA,缺陷增强TCF-1表达并支持长期持久性与功能。
- 人CAR-T中Regnase-1缺陷增强肿瘤清除、持久性和TCF-1+ CAR-T扩增。
临床怎么用
- Regnase-1可作为改造CAR-T细胞以增强持久性和抗肿瘤效力的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chimeric antigen receptor (CAR)-T-cell therapeutic efficacy is associated with long-term T-cell persistence and acquisition of memory. Memory-subset formation requires T-cell factor 1 (TCF-1), a master transcription factor for which few regulators have been identified. Here, we demonstrate using an immune-competent mouse model of B-cell acute lymphoblastic leukemia (ALL; B-ALL) that Regnase-1 deficiency promotes TCF-1 expression to enhance CAR-T-cell expansion and memory-like cell formation. This leads to improved CAR-T-mediated tumor clearance, sustained remissions, and protection against secondary tumor challenge. Phenotypic, transcriptional, and epigenetic profiling identified increased tumor-dependent programming of Regnase-1-deficient CAR-T cells into TCF-1+ precursor exhausted T cells (TPEX) characterized by upregulation of both memory and exhaustion markers. Regnase-1 directly targets Tcf7 messenger RNA (mRNA); its deficiency augments TCF-1 expression leading to the formation of TPEX that support long-term CAR-T-cell persistence and function. Regnase-1 deficiency also reduces exhaustion and enhances the activity of TCF-1- CAR-T cells. We further validate these findings in human CAR-T cells, where Regnase-1 deficiency mediates enhanced tumor clearance in a xenograft B-ALL model. This is associated with increased persistence and expansion of a TCF-1+ CAR-T-cell population. Our findings demonstrate the pivotal roles of TPEX, Regnase-1, and TCF-1 in mediating CAR-T-cell persistence and recall responses, and identify Regnase-1 as a modulator of human CAR-T-cell longevity and potency that may be manipulated for improved therapeutic efficacy.
引用
- Zheng W, Wei J, Zebley CC, et al. Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL. Blood. 2021. PMID: 33690816. doi:10.1182/blood.2020009309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。